Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

5.540 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.540
Bid (Size) 5.540 (147)
Ask (Size) 5.560 (20)
Prev. Close 5.540
Today's Range 5.540 - 5.540
52wk Range 2.770 - 5.650
Shares Outstanding 52,388,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
From ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc.
Via Business Wire
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
+35.78%
+35.78%
1 Month
N/A
N/A
3 Month
-0.18%
-0.18%
6 Month
+47.73%
+47.73%
1 Year
+61.99%
+61.99%

More News

Read More
Dow Dips Around 1%; US Small Business Optimism Falls In August
Via Benzinga
Topics Stocks
Exposures US Equities
Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
From Alimera Sciences, Inc.
Via Business Wire
A Preview Of Alimera Sciences's Earnings
Via Benzinga
ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM
From Kahn Swick & Foti, LLC
Via Business Wire
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, ALE on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRFT, SBOW, ALIM, HCP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SHCR, AGRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SBOW, AGR, RPHM on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM)
From Brodsky & Smith LLC
Via GlobeNewswire
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is MicroAlgo (MLGO) Stock Up 113% Today?
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
Via InvestorPlace
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
Via Benzinga
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 7, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.